NextCure, Inc.

NASDAQ:NXTC

1.4 (USD) • At close September 13, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 006.2840000000000000022.3782.0051.5831.4021.3570000
Kosten van de omzet 0.7010.940.8240.9461.0861.111.3631.02102.0972.1032.0961.8921.10512.10612.7411.1310.57811.3978.6637.6436.5136.314.8544.4344.21
Brutowinst -0.701-0.945.46-0.946-1.086-1.11-1.363-1.0210-2.097-2.103-2.096-1.892-1.105-12.106-12.74-11.1311.8-9.392-7.08-6.241-5.156-6.31-4.854-4.434-4.21
Brutowinstmarge 000.86900000000000-540,977,745,999.536000.527-4.684-4.473-4.451-3.80000
Onderzoek- en ontwikkelingskosten 12.41811.39811.82711.0113.44711.64712.82213.52812.82515.02412.26413.59711.94512.38612.10612.7411.1310.57811.3978.6637.6436.5136.2484.8954.4344.21
Algemene en administratieve kosten 4.0764.3643.9634.6085.7115.4244.9495.7115.3035.7474.8074.9116.0074.8484.1314.6594.6713.5882.6182.6222.7141.6590.8190.9250.8660.799
Verkoop- en marketingkosten -0.7013.42-0.82400000000000000000000000
Verkoop-, algemene en administratieve kosten 3.3753.4243.1394.6085.7115.4244.9495.7115.3035.7474.8074.9116.0074.8484.1314.6594.6713.5882.6182.6222.7141.6590.8190.9250.8660.799
Overige kosten 1.091.1971.3231.3171.2990.9750.4710.3280.2080.1690.1320.578-0.0350.7010.7761.0321.2931.5211.0831.2680.7340.660.2050.110.0690.013
Bedrijfskosten 15.79314.82214.96615.61819.15817.07117.77119.23918.12820.77117.07118.50817.95217.23416.23717.39915.80114.16614.01511.28510.3578.1727.0675.825.35.009
Bedrijfsresultaat -16.494-15.762-15.79-15.618-19.158-17.071-17.771-19.239-18.128-20.771-17.071-18.508-17.952-17.234-16.237-17.399-15.801-8.212-12.01-9.702-8.955-6.815-7.067-5.82-5.3-5.009
Bedrijfsresultaat ratio 00-2.51300000000000-725,578,693,359.5500-0.367-5.99-6.129-6.387-5.0220000
Totaal overige inkomsten en kosten netto 1.09-1.3451.3231.3171.2990.9750.4710.3280.2080.1690.1320.578-0.0350.7010.7761.0321.2931.5211.0831.2680.7340.660.2050.110.0690.013
Inkomen voor belasting -15.404-17.107-14.467-14.301-17.859-16.096-17.3-18.911-17.92-20.602-16.939-17.93-17.987-16.533-15.461-16.367-14.5089.733-10.927-8.434-8.221-6.155-6.862-5.71-5.231-4.996
Inkomen voor belasting ratio 00-2.30200000000000-690,901,778,532.487000.435-5.45-5.328-5.864-4.5360000
Belastingkosten 00.8970.9750.9860.832-0.975-0.471-0.328-0.207-0.1690000000000000000
Nettowinst -15.404-17.107-14.467-14.301-17.859-15.121-16.829-18.583-17.713-20.433-16.939-17.93-17.987-16.533-15.461-16.367-14.5089.733-10.927-8.434-8.221-6.155-6.862-5.71-5.231-4.996
Nettowinstmarge 00-2.30200000000000-690,901,778,532.487000.435-5.45-5.328-5.864-4.5360000
WPA (Winst Per Aandeel) -0.55-0.61-0.52-0.51-0.64-0.54-0.61-0.67-0.64-0.74-0.61-0.65-0.65-0.6-0.56-0.59-0.530.35-0.4-0.37-0.61-0.28-0.68-0.57-0.52-0.5
Verwaterde WPA -0.55-0.61-0.52-0.51-0.64-0.54-0.61-0.67-0.64-0.74-0.61-0.65-0.65-0.6-0.56-0.59-0.530.33-0.4-0.37-0.61-0.28-0.68-0.57-0.52-0.5
EBITDA -15.793-14.822-14.966-14.672-18.204-16.111-16.764-18.218-18.128-18.674-14.968-16.412-16.06-16.129-15.247-16.514-15.0148.963-11.255-8.914-8.373-6.252-6.549-5.424-4.913-4.633
EBITDA ratio 00-2.38200000000000-681,338,814,907.499000.401-5.613-5.631-5.972-4.6070000